Dr. Obrzut is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
20 York St # T-209
Yale-New Haven Hospital
New Haven, CT 06510Phone+1 203-688-2259Fax+1 203-688-5599
Education & Training
Yale-New Haven Medical CenterResidency, Emergency Medicine, 2009 - 2013
George Washington University School of Medicine and Health SciencesClass of 2009
Certifications & Licensure
MD State Medical License 2013 - 2025- American Board of Emergency Medicine Emergency Medicine
Publications & Presentations
PubMed
- 60 citationsLaboratory correlates for a phase II trial of romidepsin in cutaneous and peripheral T-cell lymphoma.Susan E. Bates, Zhirong Zhan, Kenneth Steadman, Tomasz Obrzut, Victoria Luchenko
British Journal of Haematology. 2010-01-01 - 20 citationsBecatecarin (rebeccamycin analog, NSC 655649) is a transport substrate and induces expression of the ATP-binding cassette transporter, ABCG2, in lung carcinoma cells.Robert W. Robey, Tomasz Obrzut, Suneet Shukla, Orsolya Polgar, Sira Macalou
Cancer Chemotherapy and Pharmacology. 2009-01-09 - 48 citationsInhibition of ABCG2-mediated transport by protein kinase inhibitors with a bisindolylmaleimide or indolocarbazole structureRobert W. Robey, Suneet Shukla, Kenneth Steadman, Tomasz Obrzut, Elizabeth M. Finley
Molecular Cancer Therapeutics. 2007-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
